Liste des publications GINECO - Cancer Ovaire 2016

Étude clinique Seribantumab Article (Journal Clinical of Oncology)
J.F. Liu
Randomized Phase II Trial of Seribantumab in Combination with Paclitaxel in Patients with Advanced Platinum-Resistant or -Refractory Ovarian Cancer.
Journal Clinical of Oncology - Octobre 2016 (réf. PubMed : PMID: 27998236 DOI: 10.1200/JCO.2016.67.1891 [PubMed - as supplied by publisher])
ESSAI AGO-OVAR-16 Article (BMC Medical Ethics)
D.J. Pulford
Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.
BMC Medical Ethics - Octobre 2016 (réf. PubMed : PMID: 27769273 DOI: 10.1186/s12910-016-0144-y [PubMed - as supplied by publisher])
ESSAI NOVA Article (Journal clinical of oncology)
M.R. Mirza
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
New England Journal of medicine - Juillet 2016 (réf. PubMed : PMID: 27717299 [PubMed - as supplied by publisher])
ESSAI PENELOPE Article (Journal clinical of oncology)
C. Kurzeder
Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).
Journal clinical of oncology - Juillet 2016 (réf. PubMed : PMID: 27269942 [PubMed - in process])
ESSAI PENELOPE Article (International J Gynecol Cancer)
A. González-Martín
Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial.
International J Gynecol Cancer - Juin 2016 (réf. PubMed : PMID: 27206218 [PubMed - as supplied by publisher])
ESSAI AGO OVAR 3, 5, 7 & 9 – Article (European Journal of Cancer)
M. Klar
Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO.
European Journal of Cancer - Octobre 2016 (réf. PubMed : PMID: 27561452 [PubMed - in process])
ESSAI COCCINELLE – Article (Journal of Clinical Oncology)
T. Sugiyama
Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.
Journal of Clinical Oncology - Août 2016 (réf. PubMed : PMID: 27400948 [PubMed - in process])
ESSAI AURELIA – Article (Gynecologic Oncology)
A. Husain
Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer.
Gynecologic Oncology - Septembre 2016 (réf. PubMed : PMID: 27184721 [PubMed - in process])
ESSAI AURELIA – Article (Annals of Oncology)
K. Lindemann
Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial.
Annals of Oncology - Août 2016 (réf. PubMed : PMID: 27407100 [PubMed - in process])
ESSAI AURELIA – Article (Annals of Oncology)
F. Trillsch
Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial.
Annals of Oncology - Juin 2016 (réf. PubMed : PMID: 27287207 [PubMed - as supplied by publisher])
ESSAIS POOLÉS FAG1 FAG2 & FAG3 – Article (Gynecologic Oncology)
F. Tinquaut
Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: results of a pooled analysis of three GINECO phase II trials.
Gynecologic Oncology - Avril 2016 (réf. PubMed : PMID: 27045777 [PubMed - as supplied by publisher])
ESSAI POLKA – Article (Journal of Clinical Oncology)
E. Pujade-Lauraine
Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study.
Journal of Clinical Oncology - Janvier 2016 (réf. PubMed : PMID: 26755507 [PubMed - indexed for MEDLINE])
GERMLINE BRCA1/2 – Article (Gynecologic Oncology)
S. Lheureux
Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
Gynecologic Oncology - Janvier 2016 (réf. PubMed : PMID: 26475959 [PubMed - indexed for MEDLINE])
DICER1 & FOXL2 – Article (Histopathology)
T. Goulvent
DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
Histopathology - Janvier 2016 (réf. PubMed : PMID: 26033501 [PubMed - in process])

Haut de page

Modifié le 30-06-2017 14:19:56